Tectonic Therapeutic to Participate in March Investor Conferences

Tectonic Therapeutic (NASDAQ: TECX) said management will participate in two investor conferences in March 2026: TD Cowen on March 4, 2026 in Boston and Leerink on March 11, 2026 in Miami.

Rhea-AI Summary

Tectonic Therapeutic (NASDAQ: TECX) said management will participate in two investor conferences in March 2026: TD Cowen on March 4, 2026 in Boston and Leerink on March 11, 2026 in Miami.

Each appearance is a fireside chat with CEO Alise Reicin, MD, available via webcast and replay on the company website for ~90 days; management will also hold one-on-one meetings by request.

Argus Mar 2 session

-1.92% close to close Open Argus

Details

News Market Reaction – TECX

In the Mar 2 session, TECX declined 1.92%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement outlines Tectonic’s participation in March 2026 investor conferences, adding to a ...

Analysis

This announcement outlines Tectonic’s participation in March 2026 investor conferences, adding to a steady cadence of communication that has included KOL events, clinical updates, and recent SEC filings. No new clinical efficacy or financial data accompany this release, so its main impact is on visibility with institutional investors via fireside chats and one-on-one meetings. In context of recent TX45 and TX2100 progress and substantial cash resources, investors may watch for any incremental disclosures or guidance shared during these events.

Key Figures

TD Cowen conference date: March 4, 2026 TD Cowen conference time: 11:10 AM EST Leerink conference date: March 11, 2026 +2 more

TD Cowen conference date

March 4, 2026

TD Cowen 46th Annual Health Care Conference fireside chat

TD Cowen conference time

11:10 AM EST

Scheduled time for TECX fireside chat

Leerink conference date

March 11, 2026

Leerink Global Healthcare Conference fireside chat

Leerink conference time

1:40 PM EST

Scheduled time for TECX fireside chat

Webcast replay period

90 days

Replay availability of conference webcasts on company website

Historical Context

5 past events · Latest: Feb 23

5 events

1. Feb 23

   Board leadership change

   24h Move

   +0.8%

   Appointment of François Nader as independent director and incoming board Chair.

2. Feb 11

   KOL event announcement

   24h Move

   +3.2%

   Announcement of TX2100-focused virtual key opinion leader event with Phase 1 plans.

3. Dec 01

   Investor conferences

   24h Move

   -4.5%

   Participation in December 2025 healthcare investor conferences and related webcasts.

4. Nov 06

   Earnings and pipeline

   24h Move

   +1.7%

   Q3 2025 results with positive TX45 Phase 1b data and solid cash runway.

5. Oct 29

   Clinical trial data

   24h Move

   -5.5%

   Positive TX45 Phase 1b Part B data in Group 2 pulmonary hypertension patients.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

g-protein coupled receptors

1 terms

g-protein coupled receptors medical

"proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs)"

Cell-surface proteins that detect outside signals — such as hormones, neurotransmitters or sensory cues — and translate them into internal actions that change how a cell behaves, like a doorbell that triggers different responses inside a house. They are prime drug targets because tweaking these receptors can alter important biological processes; successful drugs that activate or block them often drive clinical advances, approvals and significant revenue for pharmaceutical portfolios, so their status matters to investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company management will participate in two upcoming investor conferences taking place in March 2026.

TD Cowen 46th Annual Health Care Conference
Date:	March 4, 2026
Time:	11:10 AM EST
Location:	Boston, MA
Format:	Fireside Chat
Presenters:	Alise Reicin, MD, President and Chief Executive Officer
Webcast:	Link
Leerink Global Healthcare Conference
Date:	March 11, 2026
Time:	1:40 PM EST
Location:	Miami, FL
Format:	Fireside Chat
Presenters:	Alise Reicin, MD, President and Chief Executive Officer
Webcast:	Link

The live fireside chats can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. A replay of the webcasts will be available on the Company’s website for approximately 90 days.

The Tectonic management team will host one-on-one meetings during the two conferences. Interested investors should contact their TD Cowen and Leerink representatives to schedule meetings.

About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.

Contacts:

Investors:
Dan Ferry
LifeSci Advisors
(617) 430-7576
daniel@lifesciadvisors.com

Media:
Kathryn Morris
The Yates Network
(914) 204-6412
kathryn@theyatesnetwork.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Tectonic Therapeutic (TECX) present at the TD Cowen conference in March 2026?

Tectonic will present on March 4, 2026 at 11:10 AM EST in Boston. According to the company, the format is a fireside chat with CEO Alise Reicin and a live webcast accessible via the investor website.

What time and format is the Tectonic Therapeutic (TECX) appearance at the Leerink Global Healthcare Conference?

Tectonic will appear on March 11, 2026 at 1:40 PM EST in Miami as a fireside chat. According to the company, CEO Alise Reicin will present and the session will be webcast with a replay available later.

How can investors watch the Tectonic Therapeutic (TECX) webcasts for the March 2026 conferences?

Investors can access live webcasts under Events & Presentations on the company website. According to the company, replays will be available on the website for approximately 90 days after each event.

Will Tectonic Therapeutic (TECX) management hold meetings at the March 2026 conferences?

Yes, the management team will host one-on-one meetings during both conferences. According to the company, interested investors should contact their TD Cowen and Leerink representatives to schedule meetings.

Who will present for Tectonic Therapeutic (TECX) at the March 2026 investor events?

Alise Reicin, MD, President and CEO, will be the presenter at both events. According to the company, she will participate in fireside chats at TD Cowen on March 4 and Leerink on March 11, 2026.

How long will the Tectonic Therapeutic (TECX) conference webcasts remain available online?

The company will make replay webcasts available for approximately 90 days after the events. According to the company, replays can be accessed via the investor section of the Tectonic website.